Carestream Health's SuperPACS architecture allows healthcare providers to efficiently connect disparate PACS at multiple sites throughout a healthcare system.
September 26, 2008 - CryoCath Technologies Inc. announced yesterday it has resolved all outstanding patent suits among the company and Boston Scientific Corp., its wholly-owned subsidiary, CryoCor Inc., and CryoCor's co-plaintiff/co-defendant AMS Research Corp.
September 26, 2008 - The 6th annual Medical Innovation Summit at Cleveland Clinic is scheduled for Nov. 10-12 in ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 23, 2008 – In response to the FDA approval of Covidien’s ANDA for generic Kit for the Preparation of ...
September 25, 2008 - Boston Scientific Corp. announced it has received approval from the FDA to market its TAXUS ...
September 25, 2008- The use of the CVRx Rheos System in treating early-stage heart failure patients shows Rheos Therapy ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 25, 2008 - The Global Markets for Cardiac Rhythm Management (CRM) Devices 2009 report by Millennium Research ...
September 24, 2008 - Bracco Diagnostics Inc. and Lantheus Medical Imaging Inc. said yesterday they entered into an ...
September 24, 2008 - GE Healthcare’s satisfaction scores reflect significant improvements in customer perceptions of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 24, 2008 - Philips Research and the University of Urbino (Urbino, Italy) this week signed a research agreement ...
September 23, 2008 – Results of the SADHART (Safety and Efficacy of Sertraline for Depression in Patients with CHF) clinical trial were presented yesterday at the 12th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) in Toronto, presenting evidence of how treatment can improve depression and morbidity in heart failure.
September 23, 2008 - Micrus Endovascular Corp. today launched the Cerecyte and stretch-resistant versions of its DeltaPaq microcoil system for the treatment of cerebral aneurysms. The DeltaPaq system is designed to achieve 10 to 20 percent greater intra-aneurysmal packing density than conventional microcoils, the company said.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 23, 2008 – The FDA has granted approval for Covidien’s generic kit for the preparation of technetium Tc99m Sestamibi injection use for nuclear myocardial perfusion imaging.
September 23, 2008 - Digirad Corp. yesterday announced FDA clearance of its nSPEED reconstruction software, to be used ...
September 23, 2008 – Italian-based Invatec today said at the annual VIVA (Vascular InterVentional Advances) conference ...